Difference between revisions of "Endometrial carcinoma"

Jump to navigation Jump to search
Line 172: Line 172:
*CAM5.2 +ve.
*CAM5.2 +ve.
*CK34betaE12 +ve.
*CK34betaE12 +ve.
*WT1 -ve.<ref name=pmid18317227>{{Cite journal  | last1 = Soslow | first1 = RA. | title = Histologic subtypes of ovarian carcinoma: an overview. | journal = Int J Gynecol Pathol | volume = 27 | issue = 2 | pages = 161-74 | month = Apr | year = 2008 | doi = 10.1097/PGP.0b013e31815ea812 | PMID = 18317227 }}</ref>
*WT1 -ve.<ref name=pmid15084838>{{Cite journal  | last1 = Acs | first1 = G. | last2 = Pasha | first2 = T. | last3 = Zhang | first3 = PJ. | title = WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. | journal = Int J Gynecol Pathol | volume = 23 | issue = 2 | pages = 110-8 | month = Apr | year = 2004 | doi = | PMID = 15084838 }}</ref>
**Often +ve in serous.
**Often +ve/-ve in serous carcinoma of the endometrium.


Note:
Note:
Retrieved from "https://librepathology.org/wiki/Endometrial_carcinoma"